Table 1.
Summary of Reported Antibody Complex Structures for Dependoparvoviruses and Bocaparvoviruses
| Virus | Antibody/Fab | Resolution in Å | Involved VRs | Contact residues | Reference |
|---|---|---|---|---|---|
| Dependoparvovirus | |||||
| AAV1 | 4E4 | 12 | IV, V | 456–459, 492–498 | Gurda et al. (51) |
| 5H7 | 23 | V, VIII | 494, 496–499, 582, 583, 588–595, 597 | Gurda et al. (51) | |
| ADK1a | 11 | IV, V | 448, 450, 453–457, 500 | Tseng et al. (123) | |
| ADK1b | 11 | I, III, VII, IX | 256, 258, 259, 261, 263–266, 272, 385, 386, 547, 709, 710, 716–718, 720, 722 | Tseng et al. (123) | |
| AAV2 | A20 | 8.5 | I, III, VII, IX | 253, 254, 258, 261–264, 384, 385, 548, 556, 658–660, 708, 717 | McCraw et al. (81) |
| C37-B | 11 | V, VIII | 492–498, 585–589 | Gurda et al. (51) | |
| AAV4 | ADK4 | 20 | I, III, IV, V, VIII | 256–261, 375–378, 446, 487–490, 496–498, 513, 583–586 | This publication |
| AAV5 | 3C5 | 16 | I, III, V, VII, HI loop, IX | 246, 254–261, 374, 375, 483, 485–492, 494, 496, 499–501, 530, 532–538, 651, 653, 654, 656, 657, 704–708 | Gurda et al. (51) |
| ADK5a | 11 | I, III, IV, VII, HI-loop, IX | 244, 246, 248–256, 263, 377, 378, 453, 456, 532, 533, 535–543, 546, 653, 654, 656, 697, 698, 704–710 | Tseng et al. (123) | |
| ADK5b | 12 | II, IV, VII, IX | 248, 316–319, 443, 530–535, 540–543, 545, 546, 697, 704, 706, 708–710 | Tseng et al. (123) | |
| HL2476 | 3.1 | IV, V, VIII | 443, 444, 471, 481, 483, 484, 576–578 | Jose et al. (59) | |
| AAV6 | 5H7 | 15 | V, VIII | 494, 496–499, 582, 583, 588–595, 597 | Gurda et al. (51) |
| ADK6 | 13 | I, IV, VIII | 264, 266, 269, 272, 457, 588, 589 | Bennett et al. (13) | |
| AAV8 | ADK8 | 18.7 | IV, V, VIII | 456–460, 493–501, 586–591 | Gurda et al. (52) |
| AAV9 | PAV9.1 | 4.2 | V, VIII | 496–498, 588–593 | Giles et al. (44) |
| Bocaparvovirus | |||||
| HBoV1 | 4C2 | 16 | I, IV, V, VI, VIII | 81–83, 277–282, 307, 309–314, 334–336, 354–355, 392 | Kailasan et al. (60) |
| 9G12 | 8.5 | I, IV, V, VI, VIII | 81–83, 277–282, 307, 309–314, 334–336, 354–355, 392 | Kailasan et al. (60) | |
| 12C1 | 11.9 | I, IV, V, VI, VIII | 81–83, 277–282, 307, 309–314, 334–336, 354–355, 392 | Kailasan et al. (60) | |
| 15C6 | 18.6 | II, IIIB | 141–146, 461–463 | Kailasan et al. (60) | |
| HBoV2 | 15C6 | 17.8 | II, IIIB | 141–146, 457–459 | Kailasan et al. (60) |
| HBoV4 | 15C6 | 9.5 | II, IIIB | 142–147, 460–462 | Kailasan et al. (60) |
AAV, adeno-associated virus; HBoV, human bocavirus; Fab, fragment antigen binding; VR, variable region.